Oculex Pharmaceuticals, Inc. operates as a drug delivery and pharmaceutical company.
Business Model:
Revenue: $0
Employees: 51-500
Oculex Pharmaceuticals was acquired by
Allergan.
The acquisition happend on 2003-11-20.
Details of the transaction were not public
Address:
City: Sunnyvale
State: California
Zip:
Country: United States
Oculex Pharmaceuticals is an ophthalmic drug delivery company that is focused on the development of therapeutic products for the treatment of sight-threatening diseases. Oculex Pharmaceuticals develops Posurdex, a biodegradable release implant that delivers dexamethasone to the targeted disease site at the back of the eye. Oculex Pharmaceuticals was acquired by Allergan in November 2003. Oculex Pharmaceuticals was founded in 1989 and is based in Sunnyvale, California.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2002 | Series B | 6 | $50M |
Aisling Capital Bay City Capital GGV Capital Perseus-Soros Biopharmaceutical Fund Venture TDF Vivo Capital Aisling Capital Bay City Capital GGV Capital Perseus-Soros Biopharmaceutical Fund Venture TDF Vivo Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|